Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker

Skip to main content

Phase: III
Status: Not Recruiting

The purpose of this study is to evaluate the safety and effectiveness of the leadless pacemaker system in treating patients with a slow heart rate or irregular heartbeats. The Nanostim leadless pacemaker provides bradycardia pacing as a pulse generator with built-in battery and electrodes, for permanent implantation in the apex of the right ventricle. As a leadless pacemaker, it does not need a connector, pacing lead, or pulse generator pocket, but it has the same operating principles as a conventional pacemaker.

Principal Investigator

L. Bing Liem, DO


St. Jude Medical

NCT Number



Janet Lamm, Sr. Clinical Research Coordinator
Taft Center for Clinical Research

For more information about this clinical trial, including trial status, eligibility and full trial listing, visit